Suppr超能文献

口服硝苯地平与胃肠外应用异舒普明治疗早产的比较研究

Oral nifedipine and parenteral isoxsuprine in arresting preterm labor: A comparative study.

作者信息

Ray Namrata, Kshirsagar Nitin

机构信息

Department of Obstetrics and Gynecology, Krishna Institute of Medical Sciences, Karad, Maharashtra, India.

出版信息

J Family Med Prim Care. 2022 May;11(5):1845-1850. doi: 10.4103/jfmpc.jfmpc_1696_20. Epub 2022 May 14.

Abstract

OBJECTIVE

To compare the efficacy of oral nifedipine and parenteral isoxsuprine in arresting preterm labor. Considering the paucity of studies comparing these two agents, a comparative analysis is obligatory.

MATERIALS AND METHODS

Eighty antenatal women in the gestational age range of 28-37 weeks, with regular uterine contractions, cervical dilatation ≤3 cm, and <50% cervical effacement, admitted with complaints of preterm labor pain were randomized to receive either 40 mg isoxsuprine or 20 mg nifedipine. Efficacy of the drugs was measured in terms of arrest of preterm labor, prolongation of pregnancy, and the days gained by infant before birth.

RESULTS

Isoxsuprine showed increased lowering of systolic blood pressure (SBP), diastolic blood pressure (DBP), and slightly higher maternal pulse rate, but higher fetal pulse rate post-administration in comparison to nifedipine ( < 0.05). Isoxsuprine was significantly associated with more side effects. Pregnancy was more prolonged in the nifedipine group (25 days) than in the isoxsuprine group (19 days) ( < 0.05). The birth weight of neonates in group B was more than that of neonates in group A ( < 0.05). At 5 min after birth, none of the neonates in group B had an Appearance, Pulse, Grimace, Activity, and Respiration (APGAR) abnormal score <7, compared to neonates in group A. Majority of neonates in group A showed tachycardia and respiratory distress syndrome (RDS) (17.5% and 12.5%, respectively), compared to group B (12.5% and 7.5%, respectively). The overall success rate was better in group B (86.8%) compared to group A (80%).

CONCLUSION

Nifedipine was slightly more effective in arresting preterm labor with fewer side effects, compared to isoxsuprine.

摘要

目的

比较口服硝苯地平与静脉注射异舒普明抑制早产的疗效。鉴于比较这两种药物的研究较少,进行对比分析很有必要。

材料与方法

80例孕周在28 - 37周、有规律宫缩、宫颈扩张≤3 cm且宫颈消退<50%、因早产疼痛入院的产前妇女被随机分为两组,分别接受40 mg异舒普明或20 mg硝苯地平治疗。通过抑制早产、延长孕周以及婴儿出生前获得的天数来衡量药物疗效。

结果

与硝苯地平相比,异舒普明用药后收缩压(SBP)、舒张压(DBP)下降更明显,产妇脉率略高,但胎儿脉率更高(P<0.05)。异舒普明的副作用明显更多。硝苯地平组孕周延长时间(25天)比异舒普明组(19天)更长(P<0.05)。B组新生儿出生体重高于A组(P<0.05)。出生后5分钟,B组新生儿外观、脉搏、 grimace、活动和呼吸(APGAR)评分均无<7分的情况,而A组有。A组大多数新生儿出现心动过速和呼吸窘迫综合征(RDS)(分别为17.5%和12.5%),B组则分别为12.5%和7.5%。B组总体成功率(86.8%)高于A组(80%)。

结论

与异舒普明相比,硝苯地平在抑制早产方面效果稍好,且副作用更少。

相似文献

本文引用的文献

6
Preterm Labor: Prevention and Management.早产:预防与管理
Am Fam Physician. 2017 Mar 15;95(6):366-372.
7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验